がん対策推進総合研究事業
（○：委員長）
| 石塚直樹 | 京都大学医学研究科附属医療DX教育研究センター特定教授 | ||
| 生物統計学 | |||
| Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study. Takahari D, Katai H, Takashima A, Izawa N, Ishizuka N, Ohashi M, Mikami S, Wakatsuki T, Nakayama I, Chin K, Ida S, Kumagai K, Nunobe S, Iwasa S, Shoji H, Wada T, Doi A, Yoshikawa T, Sano T, Boku N, Yamaguchi K. Gastric Cancer. 2023 Jul;26(4):614-625. | |||
| Oncologic Outcomes of Laparoscopic Radical Hysterectomy Using the No-Look No-Touch Technique for Early Stage Cervical Cancer: A Propensity Score-Adjusted Analysis. Fusegi A, Kanao H, Ishizuka N, Nomura H, Tanaka Y, Omi M, Aoki Y, Kurita T, Yunokawa M, Omatsu K, Matsuo K, Miyasaka N. Cancers (Basel). 2021 Dec 3;13(23):6097. | |||
| Performance of a computer-aided diagnosis system in diagnosing early gastric cancer using magnifying endoscopy videos with narrow-band imaging (with videos). Horiuchi Y, Hirasawa T, Ishizuka N, Tokai Y, Namikawa K, Yoshimizu S, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J, Tada T. Gastrointest Endosc. 2020 Oct;92(4):856-865.e1. | |||
| 小原 明 | 東京工科大学医療保健学部看護学科 特任教授 | ||
| 小児科学・血液学・小児がん | |||
| A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia. Gocho Y, Kiyokawa N, Ichikawa H, Nakabayashi K, Osumi T, Ishibashi T, Ueno H, Terada K, Oboki K, Sakamoto H, Shioda Y, Imai M, Noguchi Y, Arakawa Y, Kojima Y, Toyama D, Hata K, Yoshida T, Matsumoto K, Kato M, Fukushima T, Koh K, Manabe A, Ohara A, Tokyo Children's Cancer Study G. Leukemia. 2015 Dec;29(12):2445-2448. | |||
| Current situation of cancer among adolescents and young adults in Japan. Ohara A, Furui T, Shimizu C, Ozono S, Yamamoto K, Kawai A, Tatara R, Higuchi A, Horibe K. Int J Clin Oncol. 2018 Dec;23(6):1201-1211. | |||
| An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia. Tanaka Y, Yeoh AEJ, Moriyama T, Li CK, Kudo K, Arakawa Y, Buaboonnam J, Zhang H, Liu HC, Ariffin H, Chen Z, Kham SKY, Nishii R, Hasegawa D, Fujimura J, Keino D, Kondoh K, Sato A, Ueda T, Yamamoto M, Taneyama Y, Hino M, Takagi M, Ohara A, Ito E, Koh K, Hori H, Manabe A, Yang JJ, Kato M. Haematologica. 2021 Jul;106(7):2026-2029. | |||
| 上別府 圭子 | 国際医療福祉大学大学院 教授 | ||
| 家族看護学 小児がん 長期フォローアップ・成人移行支援 | |||
| Morishita-Kawahara M, Koike K, Kawahara T, Kamibeppu K. The relationship between satisfaction with care and quality of life among family caregivers of patients living with terminal cancer in general wards: a cross-sectional study. Int J Palliat Nurs. 2022 Dec; 28(12):575-582. | |||
| Ishida Y, Kamibeppu K, Sato A, Inoue M, Hayakawa A, Shiobara M, Yabe H, Koike K, Adachi S, Yamashita T, Kanda Y, Okamoto S, Atsuta Y. Karnofsky performance status and visual analogue scale scores are simple indicators for quality of life in long-term AYA survivors who received allogeneic hematopoietic stem cells transplantation in childhood. Int J Hematol. 2022 July; 116(5): 787-797. | |||
| 上別府圭子(責任編者); 日本小児がん看護学会小児がん看護テキスト作成ワーキンググループ(編). 小児がん看護テキストブック. 杏林書院（2023）. (ISBN: 9784764405424) | |||
| 小松本 悟 | 足利赤十字病院 名誉院長 | ||
| 神経内科、病院管理学、病院経営マネジメント | |||
| 〈所属・役職〉 足利赤十字病院 名誉院長、日本病院会 顧問、 国際病院連盟理事（IHF: International Hospital Federation）、 アジア病院連盟会長（AHF：Asian Hospital Federation）、 日本医療機能評価機構認定病院患者安全推進事業運営委員会（PSP）委員、日本医療経営実践協会理事 業績、著書等についてはがん関連のものはありません。 |
|||
| 〈著書〉 小松本悟／いまさら聞けない病院経営～明日からの病院経営改善に向けて～/経営書院/2019年2月 小松本悟／いまさら聞けない病院経営～施設基準の重要性と適時調査・個別指導の実際～/経営書院/2021年2月 小松本悟／病院建築の現在と未来を語る（巻末付録）／編著 近藤彰宏，大宇昌利／日本医療企画／2021年3月31日発行 小松本悟／脳血管障害と自律神経症状Ⅶ-13 PP620-628／編著 田川皓一／西村書店／2010年3月10日発行 |
|||
| 小松本悟／脳血管障害と自律神経症状Ⅶ-13 PP620-628／編著 田川皓一／西村書店／2010年3月10日発行 | |||
| 永田知里 |
岐阜大学大学院医学系研究科・教授 | ||
| 専門分野 疫学、予防医学 | |||
| Association of dietary fibre intake with subsequent fasting glucose levels and indicators of adiposity in school-age Japanese children. Wada K, Nagata C, Yamakawa M, Nakashima Y, Koda S, Uji T, Tsuji M, Nagai H, Itakura N, Harada K, Takahara O, Yamanaka H. Public Health Nutr. 2023 Aug;26(8):1617-1625 | |||
| Sleep duration and the onset of menopause in Japanese women. Nagata C, Wada K, Yamakawa M, Nakashima Y, Sugino M, Mori T. Menopause. 2023 Apr 1;30(4):437-440. |
|||
| Dietary advanced glycation end products and cancer risk in Japan: From the Takayama study. Wada K, Nakashima Y, Yamakawa M, Hori A, Seishima M, Tanabashi S, Matsushita S, Tokimitsu N, Nagata C. Cancer Sci. 2022 Aug;113(8):2839-2848. | |||
| 馬場秀夫 | 熊本大学大学院生命科学研究部消化器外科学･教授 | ||
| 消化器外科学 | |||
| Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T: Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors. Cancer Res 83:753-770, 2023 | |||
| Imai K, Baba H: Initially unresectable colorectal liver metastases: the best therapeutic regimens. Lancet Oncol. 24(7):711-713, 2023 | |||
| Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, Lin SJ, Kalpana R, Tay ST, Suzuki Y, Cho BC, Kuroda D, Arima K, Izumi D, Iwatsuki M, Baba Y, Oki E, Watanabe M, Saya H, Hirakawa K, Baba H, Tan P: Activation of transforming growth factor beta 1 signaling in gastric cancer-associated fibroblasts increases their motility, via expression of rhomboid 5 homolog 2, and ability to induce invasiveness of gastric cancer cells. Gastroenterology 153:191-204 e116, 2017 | |||
| 堀田知光 | 国立病院機構名古屋医療センター 名誉院長 | ||
| 血液内科 | |||
| Ogura M, Yamamoto K, Morishima Y, Wakabayashi M, Tobinai K, Ando K, Hotta T, et al. Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406. Cancer Sci 2023 Aug;114(8):3461-3465. | |||
| Kinoshita T, Watanabe T, Itoh K, Yoshimura K, Tobinai K, Ogura M, Hotta T, et al. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study - JCOG0108A. J Clin Exp Hematop. 2021;61(1):35-41. | |||
| Watanabe T, Tobinai K, Wakabayashi M, Morishima Y, Hotta T, et al. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial. The Lancet Haematol. 2018;5(11):e520-e31. | |||
| 眞島喜幸 | NPO法人パンキャンジャパン | ||
| 専門分野： キャンサーアドボカシー、医療政策分析 | |||
| Neuro-Oncology Advances, Volume 4, Issue Supplement_3, December 2022, Page iii19, https://doi.org/10.1093/noajnl/vdac167.072 NQPC-8 UNMET NEEDS OF CANCER PATIENTS SURVEY 2022: INTERIM ANALYSIS RESULTS |
|||
| Int J Cancer.2020 Mar.1:146(5):1316-1323 Published online 2019 Oct 25. doic 10:1002/ac32678 Unmet needs in the international neuroendocrine tumor(NET)community: Assessment of major gaps from the perspective of patients, patient advocates, and NET health care professionals. |
|||
| Japanese Journal of Clinical Oncology, Volume 50, Issue 11, November 2020, Pages 1333–1341, https://doi.org/10.1093/jjco/hyaa119 Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer |
|||
| 〇 | 南 博信 | 神戸大学大学院医学研究科腫瘍・血液内科学 教授 | |
| 腫瘍内科学 | |||
| Guidelines for clinical evaluation of anti-cancer drugs. Minami HHH, Kiyota N, Kimbara S, Ando Y, Shimokata T, Ohtsu A, Fuse N, Kuboki Y, Shimizu T, Yamamoto N, Nishio K, Kawakami Y, Nihira S, Sase K, Nonaka T, Takahashi H, Komori Y, Kiyohara K. Cancer Sci 112;2563-2577, 2021 | |||
| Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial. Hayashi H, Takiguchi y, Minami H, Akiyoshi K, Segawa Y, Ueda H, Iwamoto Y Kondoh C, Matsumoto K, Takahashi S, Yasui H, Sawa T, Onozawa Y, Chiba Y, Togashi Y, Fujita Y, Sakai K, Tomida S, Nishio K, Nakagawa K. JAMA Oncol 15: 6(12):1-9, 2020 | |||
| Asciminib in tyrosine kinase inhibitor–resistant and –intolerant chronic myeloid leukemia. Hughes TP, Mauro MJ, Cortes JE, Minami H, Rea D, DeAngelo DJ, Breccia M, Goh Y-T, Talpaz, M, Hochhaus A, le Coutre P, Ottmann O, Heinrich, MC, Steegmann JL, Deininger MWN, Janssen JJWM, Mahon F-X, Minami Y, Yeung D, Ross DM, Tallman MS, Park JH, Druker BJ, Hynds D, Duan R, Meille C, Hourcade-Potelleret F, Vanasse KG, Lang F, Kim D-W. New Engl J Med 381; 2315-2326, 2019 | |||
